Zelig Eshhar
Affiliations: | Weizmann Institute of Science, Rehovot, Israel |
Area:
Oncology, Cell Biology, GeneticsGoogle:
"Zelig Eshhar"Children
Sign in to add trainee| Ariel B. Lindner | grad student | 1994-2001 | (Evolution Tree) |
| Amit Maliar | grad student | 2010 | Weizmann Institute |
| Anat Globerson-Levin | grad student | 2011 | Weizmann Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Diamant G, Simchony Goldman H, Gasri Plotnitsky L, et al. (2021) T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields. Journal of Immunology (Baltimore, Md. : 1950) |
| Levin AG, Rivière I, Eshhar Z, et al. (2021) CAR T cells: building on the CD19 paradigm. European Journal of Immunology |
| Rousso-Noori L, Mastandrea I, Talmor S, et al. (2021) P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas. Nature Communications. 12: 3615 |
| Globerson Levin A, Rawet Slobodkin M, Waks T, et al. (2020) Treatment of Multiple Myeloma using Chimeric Antigen Receptor T Cells with Dual Specificity. Cancer Immunology Research |
| Szoor A, Toth G, Zsebik B, et al. (2020) Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies. Cancer Letters |
| Globerson Levin A, Kronik N, Shiloach T, et al. (2020) Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach. Cancer Immunology, Immunotherapy : Cii |
| Diamant G, Simchony H, Shiloach T, et al. (2019) P12.05 Evaluating the compatibility of tumor treating electric fields with key antitumoral immune functions Neuro-Oncology. 21: iii60-iii60 |
| Zupančič E, Curato C, Kim JS, et al. (2018) Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine |
| Diamant G, Simchony H, Shiloach T, et al. (2018) IMMU-71. EVALUATING THE COMPATIBILITY OF TUMOR TREATING ELECTRIC FIELDS WITH KEY ANTI-TUMORAL T CELL FUNCTIONS Neuro-Oncology. 20: vi137-vi138 |
| Gross G, Eshhar Z. (2016) Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy. Annual Review of Pharmacology and Toxicology. 56: 59-83 |